• leader board size
Case Studies2020-11-19T22:10:23-08:00

Case Studies

RYTHM Reports Q3 2026 Financial Results

ROLLING MEADOWS – RYTHM, Inc. posted Q3 2026 revenue of $23.9 million, up 4% from the prior quarter and nearly six times its Q3 2025 figure. The company recorded a net loss of $533,000 alongside ...

GTI Reports Q3 2026 Financial Results

CHICAGO – Green Thumb Industries reported $324.4 million in revenue for the third quarter. Year-over-year growth of 11.3% was driven primarily by Minnesota retail sales following the state's adult-use launch in September 2025, along with ...

Big Alcohol. Big Tobacco. What About Big Marijuana?

By Mark Collins | HCN Opinion When Democratic Texas U.S. Senate candidate James Talarico identified Big Alcohol and Big Tobacco as beneficiaries of restrictions on hemp-derived THC, he raised an important question: Who profits when ...

RYTHM Reports Q3 2026 Financial Results

ROLLING MEADOWS – RYTHM, Inc. posted Q3 2026 revenue of $23.9 million, up 4% from the prior quarter and nearly six times its Q3 2025 figure. The company recorded a net loss of $533,000 alongside ...

GTI Reports Q3 2026 Financial Results

CHICAGO – Green Thumb Industries reported $324.4 million in revenue for the third quarter. Year-over-year growth of 11.3% was driven primarily by Minnesota retail sales following the state's adult-use launch in September 2025, along with ...

Jushi Reports Q2 2026 Financial Results

BOCA RATON – Jushi Holdings Inc. released its second-quarter 2026 financial results, posting revenue of $71.3 million, a 10% year-over-year gain, with growth spread across both the retail and wholesale channels. The wholesale segment set ...

Vireo Growth Sets Stage for Planet 13 Acquisition

MINNEAPOLIS - LAS VEGAS – Vireo Growth Inc. and Planet 13 Holdings Inc. have agreed to combine operations under a definitive merger agreement. The move brings together two multi-state Cannabis operators and expands retail reach ...

Q2 2026: The Quarter That Counted For Psychedelics

LOS ANGELES – Q2 2026 gave the psychedelic medicine sector the quarter that practitioners, investors, and regulators had been building up for years. Clinical programs delivered Phase 3 results, the White House signed an executive ...

Subscribe To Our Newsletter

Go to Top